Related Experiment Video
Updated: Aug 27, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
[Mechanism of Atractylodes macrocephala against Alzheimer's disease via regulating lysophagy based on LKB1-AMPK-TFEB
Li-Min Wu1, Jie Zhao2, Xiao-Wei Zhang2
1Academy of Chinese Medical Sciences, Henan University of Traditional Chinese Medicine Zhengzhou 450046,China Pharmacy College, Henan University of Traditional Chinese Medicine Zhengzhou 450046,China.
Abstract:
Myloid beta(Aβ) is produced by cleavage of amyloid precursor protein(APP), which is a main reason for Alzheimer's disease(AD) occurrence and development. This study preliminarily investigated the mechanism of Atractylodes macrocephala(AM) against AD based on LKB1-AMPK-TFEB pathway. The effect of AM on memory ability of AD transgenic Caenorhabditis elegans CL2241 was detected, and then the APP plasmid was transiently transferred to mouse neuroblastoma(N2 a) cells in vitro. The mice were divided into the blank control group, APP group(model group), positive control group(100 μmol·L~(-1) rapamycin), and AM low-, medium-and high-dose groups(100, 200 and 300 μg·mL~(-1)). The content of Aβ_(1-42) in cell medium, the protein level of APP, the fluorescence intensity of APP, the transcriptional activity of transcription factor EB(TFEB), the activity of lysosomes in autophagy, and autophagy flux were determined by enzyme-linked immunosorbent assay(ELISA), Western blot, fluorescence microscope, luciferase reporter gene assay, RLuc-LC3 wt/RLuc-LC3 G120 A, and mRFP-GFP-LC3, respectively. The protein expression of TFEB, LC3Ⅱ, LC3Ⅰ, LAMP2, Beclin1, LKB1, p-AMPK and p-ACC was detected by Western blot. Immunofluorescence and reverse transcription-polymerase chain reaction(RT-PCR) were used to detect the fluorescence intensity of TFEB and the mRNA expression of TFEB and downstream target genes, respectively. The results showed that AM reduced the chemotactic index of transgenic C. elegans CL2241, and decreased the content of Aβ in the supernatant of cell culture medium at different concentrations. In addition, AM lowered the protein level of APP and the fluorescence intensity of APP in a dose-dependent manner. Transcriptional activity of TFEB and fluorescence intensity of mRFP-GFP-LC3 plasmid were enhanced after AM treatment, and the value of RLuc-LC3 wt/RLuc-LC3 G120 A was reduced. AM promoted the protein levels of TFEB, LAMP2 and Beclin1 at different concentrations, and increased the protein expression ratio of LC3Ⅱ/LC3Ⅰ in a dose-dependent manner. Immunofluorescence results revealed that AM improved the fluorescence intensity and nuclear expression of TFEB, and RT-PCR results indicated that AM of various concentrations elevated the mRNA expression of TFEB in APP transfected N2 a cells and promoted the transcription level of LAMP2 in a dose-dependent manner, and high-concentration AM also increased the mRNA levels of LC3 and P62. The protein levels of LKB1, p-AMPK and p-ACC were elevated by AM of different concentrations. In summary, AM regulating lysophagy and degrading APP are related to the activation of LKB1-AMPK-TFEB pathway.
Insights
Atractylodes macrocephala (AM) reduces amyloid-beta (Aβ) levels in Alzheimer's disease models by activating the LKB1-AMPK-TFEB pathway, enhancing lysosome function and promoting Aβ degradation.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ), resulting from amyloid precursor protein (APP) cleavage.
- Investigating natural compounds for AD treatment is crucial due to the disease's prevalence and limited therapeutic options.
Purpose of the Study:
- To investigate the mechanism of Atractylodes macrocephala (AM) in combating Alzheimer's disease (AD).
- To explore the role of the LKB1-AMPK-TFEB pathway in AM's neuroprotective effects against Aβ accumulation.
Main Methods:
- Utilized AD transgenic Caenorhabditis elegans (CL2241) to assess memory and Aβ levels.
- Employed in vitro assays using mouse neuroblastoma (N2a) cells transfected with APP plasmid.
- Quantified Aβ, APP, TFEB transcriptional activity, lysosomal activity, and autophagy flux using ELISA, Western blot, fluorescence microscopy, and reporter gene assays.
- Analyzed protein and mRNA expression of key pathway components (LKB1, AMPK, TFEB, LC3, LAMP2) via Western blot and RT-PCR.
Main Results:
- Atractylodes macrocephala (AM) reduced Aβ levels and APP expression in both C. elegans and N2a cells.
- AM treatment enhanced TFEB transcriptional activity, lysosomal activity, and autophagy flux, indicated by increased LC3-II/LC3-I ratio and mRFP-GFP-LC3 fluorescence.
- AM upregulated the expression of TFEB, LAMP2, Beclin1, LKB1, p-AMPK, and p-ACC, suggesting activation of the LKB1-AMPK-TFEB pathway.
Conclusions:
- Atractylodes macrocephala (AM) demonstrates neuroprotective effects against Alzheimer's disease (AD) pathology by reducing Aβ accumulation.
- AM's mechanism involves the activation of the LKB1-AMPK-TFEB pathway, leading to enhanced lysophagy and degradation of APP and Aβ.
- These findings suggest AM as a potential therapeutic agent for Alzheimer's disease (AD).
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

